A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this Phase 2 Study was to compare the safety of 3 liter(L) and 4
liter(L) split dose DCL-101 to split dose 4L GoLYTELY in patients preparing for colonoscopy,
with secondary objectives to assess tolerability and bowel cleansing efficacy.